Biotech by one-year price change
How far the share price has moved over the last 52 weeks.
CRISPR Therapeutics has the lowest figure of the 24 biotech ranked by one-year price change, at -20.9%, followed by BioNTech (-16.3%) and argenx (+3.60%). Figures as of 18 Nov 2026, 16:15 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 24
- Lowest
- CRISPR Therapeutics-20.9%
- Median
- +40.0%
- Combined market value
- AED 3.08T
- Countries
- 5
Market values as of .
All countries▾
All sectors▾
Biotech▾
| # | Company | 1 year ↑ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | CRISPR TherapeuticsCRSP · Health Care | -20.9% | AED 14.7B | AED 151.80 | 2.94% up | 21% down | ||
| 2 | BioNTechBNTX · Health Care | -16.3% | AED 76.5B | AED 308.53 | 1.01% down | 16% down | ||
| 3 | argenxARGX · Health Care | +3.60% | AED 218.5B | AED 3,474.43 | 0.16% down | 4% up | ||
| 4 | RepligenRGEN · Health Care | +4.58% | AED 40B | AED 626.49 | 5.17% up | 5% up | ||
| 5 | QiagenQGEN · Health Care | +12.0% | AED 37.6B | AED 182.05 | 0.37% down | 12% up | ||
| 6 | Scholar Rock HoldingSRRK · Health Care | +13.6% | AED 21.2B | AED 173.84 | 4.99% up | 14% up | ||
| 7 | Neurocrine BiosciencesNBIX · Health Care | +20.2% | AED 60.4B | AED 596.50 | 2.12% down | 20% up | ||
| 8 | VaxcytePCVX · Health Care | +22.2% | AED 34.3B | AED 216.39 | 0.82% down | 22% up | ||
| 9 | Bio-TechneTECH · Health Care | +25.6% | AED 42B | AED 267.11 | 0.13% up | 26% up | ||
| 10 | Gilead SciencesGILD · Health Care | +32.9% | AED 767.7B | AED 618.94 | 1.02% down | 33% up | ||
| 11 | AmgenAMGN · Health Care | +33.7% | AED 887.5B | AED 1,640.83 | 2.44% down | 34% up | ||
| 12 | Halozyme TherapeuticsHALO · Health Care | +36.6% | AED 40.6B | AED 356.03 | 1.01% up | 37% up | ||
| 13 | ImmunovantIMVT · Health Care | +43.4% | AED 25.6B | AED 123.54 | 1.28% up | 43% up | ||
| 14 | Krystal BiotechKRYS · Health Care | +46.3% | AED 33.6B | AED 1,133.33 | 3.35% up | 46% up | ||
| 15 | BiogenBIIB · Health Care | +49.3% | AED 135.4B | AED 916.20 | 0.53% down | 49% up | ||
| 16 | ExelixisEXEL · Health Care | +62.6% | AED 61.8B | AED 253.14 | 0.61% up | 63% up | ||
| 17 | CG OncologyCGON · Health Care | +85.3% | AED 26.1B | AED 292.33 | 0.82% up | 85% up | ||
| 18 | Kymera TherapeuticsKYMR · Health Care | +87.5% | AED 37.8B | AED 443.32 | 0.67% down | 87% up | ||
| 19 | Adaptive BiotechnologiesADPT · Health Care | +88.1% | AED 16.7B | AED 103.25 | 1.33% down | 88% up | ||
| 20 | Revolution MedicinesRVMD · Health Care | +131% | AED 127.1B | AED 587.66 | 1.65% down | 131% up | ||
| 21 | ImmunityBioIBRX · Health Care | +193% | AED 25.8B | AED 24.24 | 5.43% up | 193% up | ||
| 22 | Twist BioscienceTWST · Health Care | +340% | AED 28.8B | AED 422.20 | 2.63% up | 340% up | ||
| 23 | Kodiak SciencesKOD · Health Care | +396% | AED 23.1B | AED 353.41 | 0.60% down | 396% up | ||
| 24 | ModernaMRNA · Health Care | +755% | AED 298.2B | AED 737.10 | 2.96% down | 755% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Sums are converted from US dollars at today's exchange rate (1 USD = 3.6729 AED).
Questions and answers
Which biotech have the lowest one-year price change?
CRISPR Therapeutics (-20.9%), BioNTech (-16.3%) and argenx (+3.60%) have the lowest one-year price change of the 24 biotech ranked here as of 18 Nov 2026, 16:15 UTC.
How many biotech are in this ranking?
24 are ranked by one-year price change.
What are these biotech worth together?
The 24 biotech ranked by one-year price change have a combined market value of AED 3.08T as of 18 Nov 2026, 16:15 UTC.
What does ranking by one-year price change measure?
How far the share price has moved over the last 52 weeks.
Learn how this ranking works
All markets guides →- 52-week high and low: what the range tells you
A stock's 52-week high and low are the highest and lowest prices it reached over the past year. Where today's price sits in that range, from 0% at the low to 100% at the high, shows how the past year has gone. Sources differ on whether they use closing or intraday prices, so the same stock's range can differ slightly.
- Drawdown and recovery: why a 50% fall needs a 100% gain
A drawdown is how far a price has fallen from its previous peak, as a percentage of that peak. Recovery needs a larger gain than the fall, because the gain starts from a smaller base: a 20% drop needs a 25% rise to get back, a 50% drop needs 100%, and a 75% drop needs 300%.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Biotech by one-year price change”, data as of 18 November 2026. https://funkfolio.com/companies/category/biotech?by=year-change
Underlying data: Yahoo Finance; SEC EDGAR.